LC
ESPR

Lindbrook Capital’s Esperion Therapeutics ESPR Stock Holding History

Lindbrook Capital’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-255
Closed -$561 – 2826
2024
Q4 		$561 Hold
255
– – ﹤0.01% 2590
2024
Q3 		$421 Buy
+255
New +$515 ﹤0.01% 2709
2023
Q2 		– Sell
-825
Closed -$1.31K – 2760
2023
Q1 		$1.31K Sell
825
-686
-45% -$3.54K ﹤0.01% 2397
2022
Q4 		$9.41K Buy
1,511
+285
+23% +$2.04K ﹤0.01% 1465
2022
Q3 		$8K Sell
1,226
-22
-2% -$151 ﹤0.01% 1415
2022
Q2 		$8K Sell
1,248
-426
-25% -$2.42K ﹤0.01% 1345
2022
Q1 		$8K Buy
+1,674
New +$7.18K ﹤0.01% 1372
2019
Q2 		– Sell
-300
Closed -$12K – 1428
2019
Q1 		$12K Buy
+300
New +$13.5K ﹤0.01% 838

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return